相关实验视频

Updated: Jun 1, 2025

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

德卡瓦纳达特化合物在黑色素瘤模型上显示了体外和体外抗瘤效应

Amine Essid¹, Ines Elbini¹, Regaya Ksiksi²

¹Institut Pasteur de Tunis, LR20IPT01 Biomolécules, Venins et Application Théranostiques (LBVAT), University of Tunis El Manar, Tunis 1002, Tunisia.

Bioinorganic chemistry and applications

|January 21, 2025

概括

一种新型的decavanadate化合物,Mg2Na2V10O28·20H2O,显示出显著的抗黑色素瘤作用,减少瘤活力和转移在体外和体内. 这种有前途的药物对正常细胞具有较低的毒性,相比于西斯,为黑色素瘤提供了潜在的新疗法策略.

科学领域:

无机化学无机化学
材料科学材料科学材料科学
癌症研究癌症研究

背景情况:

目前的黑色素瘤治疗因副作用和治疗耐药性而面临局限性.
德卡瓦纳达特化合物显示出作为治疗癌症治疗的治疗剂的潜力.

研究的目的:

为了合成和描述一种新型的甲卡瓦纳化合物,Mg2Na2V10O28·20H2O.
为了研究这种化合物的结构稳定性和抗黑色素瘤作用.
为了比较它的疗效和毒性与西斯.

主要方法:

合成和结构分析Mg2Na2V10O28·20H2O使用X射线衍射.
在人体和小鼠黑色素瘤细胞系 (IGR39,IGR37,SKMEL28,B16-F10) 和正常的人类角质细胞 (HaCaT) 的体外细胞毒性测定.
在体外抑制细胞粘附和迁移的测试.
在体内对B16-F10全移植小鼠进行研究,以评估瘤生长抑制和抗炎作用.

主要成果:

化合物Mg2Na2V10O28·20H2O在单临床系统 (空间组C2/c) 中结晶.
在72小时后,它显示了黑色素瘤细胞活力的剂量依赖性降低,IC50值明显低于西斯.
该化合物在HaCaT细胞上表现出较弱的细胞毒性,与西斯不同.
观察到抑制黑色素瘤细胞粘附和迁移.
在体内,无毒剂量抑制了70%的瘤生长,并减少了炎症.

结论:

Mg2Na2V10O28·20H2O是一种结构稳定的化合物,具有强大的抗黑色素瘤活性.
与西斯相比,它显示出一个有利的治疗指数.
该化合物有效地抑制黑色素瘤细胞粘附,迁移和瘤生长.
德卡瓦纳酸化合物代表了治疗黑色素瘤的一类有前途的药物.

关键词:

抗瘤剂是一种抗瘤剂.癌症抑制剂癌症抑制剂细胞迁移细胞迁移德卡瓦纳已经过期了.黑色素瘤是一种黑色素瘤.聚氧甲基酸盐是一种多氧甲基酸盐.聚乙酸的使用方法

更多相关视频

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Drugs that Destabilize Microtubules

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...